Navigation Links
Trans-Atlantic agreement a boost to neuroscience research
Date:5/10/2010

This release is available in French.

Neurological research and clinical care received a significant boost today as Imperial College London and McGill University of Montreal entered an agreement enabling them to work more closely together in this field. Sir Keith O'Nions, Rector of Imperial, and Heather Munroe-Bloom, Principal and Vice-Chancellor of McGill, met in London to sign the partnership documents, which will consolidate existing scientific collaborations and provide new support for creating a framework for regular academic interactions.

"McGill and Imperial share common interests and strengths in such important fields of transformational research as brain imaging, motor neuron diseases, movement disorders and neuroimmunology," Munroe-Blum said. "I am delighted that the long-standing collaboration between these two leading institutions has been broadened, offering us the opportunity to strengthen and expand our research programs and eventually achieve major advances in our understanding of human neurological disorders."

"The neurosciences are an extremely important and interdisciplinary field of research focused on some of the major health challenges we face today," said Sir Keith. "We are making great strides in understanding how the brain works physically and biochemically, and this work is key to improving mental health. We at Imperial are delighted to have as our partner a leading institution that shares our appetite to carry out excellent research and move it quickly out of the lab to create new therapies for the people who need it."

Neurosciences research is one of McGill's top institutional priorities, building on the distinguished history and current strengths of its Montreal Neurological Institute (MNI) and the Douglas Mental Health University Institute. McGill's integrated program in neurosciences is one of the largest contemporary neuroscience graduate programs in North America. At Imperial, neurosciences research focuses particularly on mechanisms of brain degeneration and restoration of function, systems neuroscience, brain development, pain, anaesthesia, muscular dystrophy, neuroinflammatory disorders such as multiple sclerosis, addiction, molecular neuroimaging, cognitive neuroscience, neurogenetics and various aspects of mental health. Research achievements at the College include the first demonstration that variant CJD is caused by the same prion as BSE.


'/>"/>

Contact: William Raillant-Clark
william.raillant-clark@mcgill.ca
514-398-2189
McGill University
Source:Eurekalert  

Related medicine news :

1. EPA and NASA administrators to extend environmental and Earth science agreement
2. More common ground in health care reform law disagreement than meets the eye
3. BCS Global and Iformata Sign Agreement to Collaborate on the PSVN Initiative to Deliver B2B Video Communications
4. Online Tech and VersaIMAGE Sign SaaS Hosting Agreement
5. VisionQwest Global Group Signs Distribution Agreement with Creative Trade World, Inc.
6. Oridion and Masimo Sign Distribution Agreement to Sell Capnostream™20 Bedside Monitors with the Masimo Patient SafetyNet™ System
7. Online Tech and Healthmaster Sign SaaS Hosting Agreement
8. Stellaris Health Network Hospitals Reach New Agreement with CIGNA HealthCare
9. Sigma-Aldrich Reaches Agreement to Sell Pfizers Bioactive Small Molecule Compounds
10. Historic Agreement Reached to Transition Illinois Residents Unnecessarily Housed in Large, Impersonal Nursing Homes
11. Brain Science Institute announces license agreement to develop treatments for neurological disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Trans-Atlantic agreement a boost to neuroscience research
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... While it’s ... poses a problem. Fortunately, an inventor from Austin, Texas, has identified a solution. , ... medication in darkness or restricted lighting. As such, it eliminates the need to turn ...
(Date:10/13/2017)... , ... October 13, 2017 , ... PurhealthRX , ... Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize ... providing a CBD form that can be easily incorporated into liquid products, while reducing ...
(Date:10/13/2017)... Shelton, CT (PRWEB) , ... October 13, 2017 , ... ... and long-term care services, staged a mock evacuation of the facility as part of ... Department, Shelton Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well ...
(Date:10/13/2017)... NY (PRWEB) , ... October 13, 2017 , ... Ellevate ... people in business to advocate for action towards gender equality at their inaugural Summit ... from around the globe, and reached a social audience of over 3 million. To ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... be giving viewers the lowdown on sciatica in a new episode of "Success ... focuses on current events and innovation and investigates each subject in-depth with passion ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
(Date:9/19/2017)... 19, 2017   ZirMed Inc ., a recognized leader ... that it has been ranked #1 by its users for ... Rankings 2017 User Survey. ZirMed was recognized as the top-ranked ... and medical centers over 200 beds and holds one of ... user survey history. ...
(Date:9/12/2017)... PARIS and NEW YORK , Sept. 12, ... ethical performance ratings for global supply chains, has published the first annual ... the CSR performance of more than 20,400 companies evaluated by EcoVadis, based ... years 2015 and 2016. ... EcoVadis Global CSR Risk & Performance Index ...
Breaking Medicine Technology: